AnaptysBio, Inc. (ANAB) has a market capitalization of $2.02B and trades at $70.22. The 52-week range is 15.4-68.39.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -152.7, Earnings Per Share (EPS) of $-0.46, annual revenue of $234.6M.
The stock has a beta of 0.41, operates in the Healthcare sector.
